Patents by Inventor Terumi Nakajima
Terumi Nakajima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7560286Abstract: A method for effectively causing charge-remote fragmentation (CRF) when the structural analysis of an nitrogen-containing organic compound is performed using a high-energy collisional-induced dissociation-mass/mass spectrum (CID-MS/MS spectrum), a reagent to be used in such a method, and a method for analyzing an organic compound by the induction of CRF are provided. The method for the induction of charge-remote fragmentation (CRF) using a high-energy collisional-induced dissociation-mass/mass spectrum (CID-MS/MS spectrum) has the step of: introducing a squaric acid residue into an end of a nitrogen-containing organic compound. The squaric acid residue is represented by a chemical formula (I): The reagent is provided for introducing such a squaric acid residue. Furthermore, the method is provided for analyzing such an organic compound by the induction of CRF.Type: GrantFiled: March 12, 2002Date of Patent: July 14, 2009Assignee: Suntory Holdings LimitedInventors: Hideo Naoki, Terumi Nakajima, Yasufumi Ohfune, Tetsuro Shinada, Kazuya Murata
-
Patent number: 7282577Abstract: Hemolytic proteins offer new approaches to drug development. The hemolytic proteins are obtained from a nematocyst of Carybdea alata. Alternatively, the proteins may be recovered from cultured cells transfected with the sequence encoding the hemolytic protein of Carybdea alata.Type: GrantFiled: December 30, 2004Date of Patent: October 16, 2007Assignee: Suntory LimitedInventors: Hiroshi Nagai, Kyoko Kuroda, Terumi Nakajima
-
Patent number: 7250491Abstract: Novel proteins providing the new approach to development of the drugs and pesticides with the use or application of a hemolytic activity, and novel proteins having the following properties and the genes encoding thereof are provided: (1) having hemolytic activity; (2) having a molecular weight of about 50,000 Da (determined by SDS gel electrophoresis); (3) having an amino acid sequence represented by any of SEQ ID NO 1 to SEQ ID NO 3 as a partial amino acid sequence; and (4) having an amino acid sequence represented by SEQ ID NO 5 as the full amino acid sequence.Type: GrantFiled: August 29, 2003Date of Patent: July 31, 2007Assignee: Suntory LimitedInventors: Hiroshi Nagai, Terumi Nakajima
-
Publication number: 20050106676Abstract: Hemolytic proteins offer new approaches to drug development. The hemolytic proteins are obtained from a nematocyst of Carybdea alata. Alternatively, the proteins may be recovered from cultured cells transfected with the sequence encoding the hemolytic protein of Carybdea alata.Type: ApplicationFiled: December 30, 2004Publication date: May 19, 2005Applicant: SUNTORY LIMITEDInventors: Hiroshi Nagai, Kyoko Kuroda, Terumi Nakajima
-
Publication number: 20050074864Abstract: Novel proteins providing the new approach to development of the drugs and pesticides with the use or application of a hemolytic activity, and novel proteins having the following properties and the genes encoding thereof are provided: (1) having hemolytic activity; (2) having a molecular weight of about 50,000 Da (determined by SDS gel electrophoresis); (3) having an amino acid sequence represented by any of SEQ ID NO 1 to SEQ ID NO 3 as a partial amino acid sequence; and (4) having an amino acid sequence represented by SEQ ID NO 5 as the full amino acid sequence.Type: ApplicationFiled: August 29, 2003Publication date: April 7, 2005Applicant: Suntory LimitedInventors: Hiroshi Nagai, Terumi Nakajima
-
Patent number: 6855803Abstract: Novel proteins having hemolytic activity giving the new approach of development of the drugs, and having the following property are provided: (1) having hemolytic activity; (2) having a molecular weight of about 50,000 Da (determined by SDS gel electrophoresis); and (3) having an amino acid sequence represented by any of SEQ ID NO 1 and SEQ ID NO 2 as a partial amino acid sequence represented by the following amino acid sequences (1) and (2); Amino acid sequence (1): Tyr-Arg-Asp-Gln-Glu-Leu-Glu-Asp-Asn-Val-Lys Amino acid sequence (2): Lys-Trp-Pro-Asp-Tyr-Phe-Val-Tyr-Met-Glu-Ser-Ser-Ala-His-Gly-Tyr-Ile-Arg (wherein, an amino acid residue is written by the 3 letters notation defined by IUPAC and IUB) obtained from nematocyst of Carybdea alata.Type: GrantFiled: March 21, 2001Date of Patent: February 15, 2005Assignee: Suntory LimitedInventors: Hiroshi Nagai, Terumi Nakajima, Kyoko Kuroda
-
Publication number: 20040235062Abstract: A method is disclosed for identifying or analyzing, easily and in a short time, the molecular weight, the chemical species of molecules, and the structure of molecules, of a protein present on the superficial layer of cells or in cells, or a substance interacting with the protein. This method comprises the steps of: bringing the cells having the protein and the substance interacting with the protein into contact with each other to cause the substance to interact with the cells; purifying the cells, with the cells and the substance in an interacting state; irradiating the purified cells with a laser to ionize the substance directly; and analyzing the ionized substance by mass spectrometry.Type: ApplicationFiled: June 22, 2004Publication date: November 25, 2004Inventors: Terumi Nakajima, Hideo Naoki, Akikazu Yasuda, Keiko Iwasa
-
Publication number: 20040137420Abstract: An improved method for directly identifying a chemical structure of a substance present in tissue or cells of organisms is disclosed.Type: ApplicationFiled: December 13, 2002Publication date: July 15, 2004Inventors: Akikazu Yasuda, Yoshimi Yasuda, Terumi Nakajima
-
Publication number: 20040110919Abstract: Novel proteins having hemolytic activity giving the new approach of development of the drugs, and having the following property are provided:Type: ApplicationFiled: November 21, 2001Publication date: June 10, 2004Inventors: Hiroshi Nagai, Terumi Nakajima
-
Publication number: 20040067525Abstract: A method for effectively causing charge-remote fragmentation (CRF) when the structural analysis of an nitrogen-containing organic compound is performed using a high-energy collisional-induced dissociation-mass/mass spectrum (CID-MS/MS spectrum), a reagent to be used in such a method, and a method for analyzing an organic compound by the induction of CRF are provided. The method for the induction of charge-remote fragmentation (CRF) using a high-energy collisional-induced dissociation-mass/mass spectrum (CID-MS/MS spectrum) has the step of: introducing a squaric acid residue into an end of a nitrogen-containing organic compound.Type: ApplicationFiled: March 12, 2002Publication date: April 8, 2004Applicant: Suntory LimitedInventors: Hideo Naoki, Terumi Nakajima, Yasufumi Ohfune, Tetsuro Shinada, Kazuya Murata
-
Patent number: 6689749Abstract: The invention provides a peptide capable of blocking voltage-gated K+ channels and inhibiting IL-2 production, which is represented by an amino acid sequence of: Ala-Ser-Cys-Arg-Thr-Pro-Lys-Asp-Cys-Ala-Asp-Pro-Cys-Arg-Lys-Glu-Thr-Gly-Cys-Pro-Tyr-Gly-Lys-Cys-Met-Asn-Arg-Lys-Cys-Lys-Cys-Asn-Arg-Cys; in which the C-terminal is amidated and four disulfide bridges are present in the molecule, and their related peptides isolated from the venom gland of a scorpion Heterometrus spinnifer. The peptides provided by the present invention are neuropeptides which can block voltage-gated K+ channels and inhibit IL-2 production at an extremely low concentration and, therefore, are expected to contribute to application of scorpion toxins to medicines and so on.Type: GrantFiled: August 26, 1998Date of Patent: February 10, 2004Assignee: Suntory LimitedInventors: Bruno Lebrun, RĂ©gine Romi-Lebrun, Hiroyuki Minakata, Terumi Nakajima, Junko Hashino
-
Patent number: 6653449Abstract: Novel proteins providing the new approach to development of the drugs and pesticides with the use or application of a hemolytic activity, and novel proteins having the following properties and the genes encoding thereof are provided: (1) having hemolytic activity; (2) having a molecular weight of about 50,000 Da (determined by SDS gel electrophoresis); (3) having an amino acid sequence represented by any of SEQ ID NO 1 to SEQ ID NO 3 as a partial amino acid sequence; and (4) having an amino acid sequence represented by SEQ ID NO 5 as the full amino acid sequence.Type: GrantFiled: December 1, 2000Date of Patent: November 25, 2003Assignee: Suntory LimitedInventors: Hiroshi Nagai, Terumi Nakajima
-
Patent number: 5246968Abstract: A compound having glutamate receptor inhibitor activity represented by the formula: ##STR1## where R represents a hydrogen atom or a group of the formula: ##STR2## m and n each represents an integer of 3 or 4 and p represents an integer of 0 or 1, or a salt thereof is provided. The compounds are useful for an insecticide.Type: GrantFiled: June 30, 1992Date of Patent: September 21, 1993Assignees: Takeda Chimical Industries, Ltd., Tokyo Metropolitan Institute for NeurosciencesInventors: Terumi Nakajima, Yoshio Aramaki, Tadashi Yasuhara, Tsutomu Higashijima, Nobufumi Kawai, Akiko Miwa, Masanori Yoshioka
-
Patent number: 5047430Abstract: A compound is provided which has the formula ##STR1## wherein m is an integer of 1 to 3;n is an integer of 1 or 2;p is an integer of 1 or 2;q is an integer of 1 to 6;x is an integer of 2 to 6;Ph is phenyleneor a pharmceutically acceptable salt thereof. Also provided is a method for glutamate receptor inhibition which comprises administering to a mammal in need thereof an effective amount of said compound or a pharmaceutically acceptable salt thereof. Compositions for glutamate receptor inhibition are provided which contain an effective amount of said compound to provide a glutamate receptor inhibition effect, together with at least one pharmaceutically acceptable carrier, dilient or excipient therefor.Type: GrantFiled: April 25, 1989Date of Patent: September 10, 1991Assignee: Takeda Chemical Industries, Ltd.Inventors: Giichi Goto, Terumi Nakajima
-
Patent number: 4990511Abstract: Amide compounds having glutamate receptor-inhibiting activity and having the formula: ##STR1## (wherein R.sub.1 and R.sub.2 each is hydrogen atom, an alkyl group or an acyl group, or ##STR2## is a cyclic amino group, m is an integer of 1 to 3, n is an integer of 0 to 4, x is an integer of 2 to 6 and y is an integer of 0 to 3) or salts thereof, are provided. The compounds are useful as a medicine for therapy or/and prevention of sequelae of cerebral apoplexy in warm-blooded animals.Type: GrantFiled: August 2, 1989Date of Patent: February 5, 1991Assignee: Takeda Chemical Industries, Ltd.Inventors: Terumi Nakajima, Koichi Shudo, Giichi Goto
-
Patent number: 4990614Abstract: A compound of the formula: ##STR1## wherein ##STR2## represents a cyclic amino group, A represents a methylene group or a carbonyl group, m represents an integer of 1 to 3, n represents an integer of 0 to 4 and p represents an integer of 1 to 2, or a salt thereof, which has glutamate receptor inhibiting activity is provided.Type: GrantFiled: October 5, 1988Date of Patent: February 5, 1991Assignee: Takeda Chemical Industries, Ltd.Inventors: Terumi Nakajima, Koichi Shudo, Giichi Goto
-
Patent number: 4918107Abstract: A compound of the formula ##STR1## wherein R' is hydrogen atom or an alkyl group, m is an integer of 1 to 3, p is 1 or 2, x is an integer of 2 to 6, and y is an integer of 1 to 3, or a salt thereof, which has glutamate receptor inhibitor activity, a process for preparing the same and an insecticidal composition containing the same are provided.Type: GrantFiled: June 6, 1988Date of Patent: April 17, 1990Assignees: Tsumura & Co., Tokyo Metropolitan Institute for Neurosciences, Takeda Chemical Industries, Ltd.Inventors: Terumi Nakajima, Nobufumi Kawai, Koichi Shudo, Tetsuo Shiba